Bluejay Diagnostics (BJDX) Shares Outstanding (Weighted Average) (2022 - 2023)
Historic Shares Outstanding (Weighted Average) for Bluejay Diagnostics (BJDX) over the last 2 years, with Q3 2023 value amounting to $137871.0.
- Bluejay Diagnostics' Shares Outstanding (Weighted Average) fell 8631.71% to $137871.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $137871.0, marking a year-over-year decrease of 8631.71%. This contributed to the annual value of $1.0 million for FY2022, which is N/A changed from last year.
- Latest data reveals that Bluejay Diagnostics reported Shares Outstanding (Weighted Average) of $137871.0 as of Q3 2023, which was down 8631.71% from $127881.0 recorded in Q2 2023.
- Over the past 5 years, Bluejay Diagnostics' Shares Outstanding (Weighted Average) peaked at $20.1 million during Q1 2022, and registered a low of $127881.0 during Q2 2023.